Anthracycline antibiotics with significant antitumor activity are widely used for treatment of various oncologic diseases in spite of their poor pharmacokinetics and severe side-effects. To improve the efficacy of treatment of oncologic patients, liposomal formulations of the anthracycline antibiotics, such as Doxil, TLC D-99, and DaunoXome, have been developed. Pharmacokinetic parameters of liposomal doxorubicin and daunorubicin differ markedly from the parameters of their free formulations. Liposomal anthracyclines display a prolonged circulation time, reduced clearance, smaller volume of distribution, and lower toxicity. Doxil and DaunoXome have been licensed for treatment of AIDS-related Kaposi's sarcoma. Entrapment of anthracycline antibiotics into liposomes coupled with monoclonal antibodies enhances their uptake by tumor cells.
Berezov T.T. et al. Liposomal formulations of anthracycline antibiotics // Biomeditsinskaya Khimiya. - 2004. - V. 50. -N 5. - P. 412-419.
Berezov T.T. et al., "Liposomal formulations of anthracycline antibiotics." Biomeditsinskaya Khimiya 50.5 (2004): 412-419.
Berezov, T. T., Yaglova, N. V., Chekhonin, V. P., Zhirkov, Yu. A. (2004). Liposomal formulations of anthracycline antibiotics. Biomeditsinskaya Khimiya, 50(5), 412-419.
References
Gabizon A., Huang A., Martin E., Barenholz Y. (1995) in: Stealth Liposomes (D. Lasic and F. Martin, Eds.) CRC Press, London, pp. 245- 255. Scholar google search
Gabizon A., Papahadjopoulos D. (1992) Biochim. Biophys. Acta, 1103, 94- 100. Scholar google search
Parr M., Bally M., Cullis P. (1993) Biochim. Biophys. Acta, 1168, 249- 252. Scholar google search
Gabizon A., Shiota R., Papahadjopoulos D. (1989) J. Natl. Cancer Inst., 81, 1484- 1488. Scholar google search
Gabizon A, Catane R., Uziely В., Kaufman В. et ей. (1994) Cancer Res., 54, 987- 992. Scholar google search
Den Boer M., Pieters R., Kazemier K. (1999) Leukemia, 13, 2023- 2030. Scholar google search
Borg A., Burgess R., Green L. (2000) Br. J. HaematoJ., 108, 48- 54. Scholar google search
Soma C., Dubernet C., Barratt G. (1999) Pharm. Res., 16, 1710- 1716. Scholar google search
Verdonck L., Lokhorst H., Roovers D., van Heugten H. (1998) Leukemia Res., 22, 249- 256. Scholar google search
Northfelt D. W., Kaplan L., Russell J., Lang J., Volberding P., Martin F. (1995) in: Stealth Liposomes (D. Lasic and F. Martin, Eds.) CRC Press, London, pp. 257- 266. Scholar google search
Marina N., Cochrane D., Harney E., Zamorodi K., Blaney S., Winick N., Bernstein M., Link M. (2002) Clin. Cancer Res., 8, 413- 418. Scholar google search
Ten Hagen Т., Takahashi N., van Tiel S., Hostens J., Eggermont A., Seynhaeve A., Fiers W., Brouckaert P. (2000) J. Liposome Res., 10, 286- 287. Scholar google search
